scholarly journals Cell Invasion Dynamics into a Three Dimensional Extracellular Matrix Fibre Network

2015 ◽  
Vol 11 (10) ◽  
pp. e1004535 ◽  
Author(s):  
Min-Cheol Kim ◽  
Jordan Whisler ◽  
Yaron R. Silberberg ◽  
Roger D. Kamm ◽  
H. Harry Asada
2012 ◽  
Vol 2 (6) ◽  
pp. 790-794 ◽  
Author(s):  
Yoojin Shin ◽  
Hyunju Kim ◽  
Sewoon Han ◽  
Jihee Won ◽  
Hyo Eun Jeong ◽  
...  

2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Massimo Alfano ◽  
Manuela Nebuloni ◽  
Raffaele Allevi ◽  
Pietro Zerbi ◽  
Erika Longhi ◽  
...  

2019 ◽  
Vol 5 (11) ◽  
pp. 5669-5680 ◽  
Author(s):  
Naoko Nakamura ◽  
Tsuyoshi Kimura ◽  
Kwangwoo Nam ◽  
Toshiya Fujisato ◽  
Hiroo Iwata ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (7) ◽  
pp. 1629
Author(s):  
Colin H. Quinn ◽  
Andee M. Beierle ◽  
Elizabeth A. Beierle

In the quest to advance neuroblastoma therapeutics, there is a need to have a deeper understanding of the tumor microenvironment (TME). From extracellular matrix proteins to tumor associated macrophages, the TME is a robust and diverse network functioning in symbiosis with the solid tumor. Herein, we review the major components of the TME including the extracellular matrix, cytokines, immune cells, and vasculature that support a more aggressive neuroblastoma phenotype and encumber current therapeutic interventions. Contemporary treatments for neuroblastoma are the result of traditional two-dimensional culture studies and in vivo models that have been translated to clinical trials. These pre-clinical studies are costly, time consuming, and neglect the study of cofounding factors such as the contributions of the TME. Three-dimensional (3D) bioprinting has become a novel approach to studying adult cancers and is just now incorporating portions of the TME and advancing to study pediatric solid. We review the methods of 3D bioprinting, how researchers have included TME pieces into the prints, and highlight present studies using neuroblastoma. Ultimately, incorporating the elements of the TME that affect neuroblastoma responses to therapy will improve the development of innovative and novel treatments. The use of 3D bioprinting to achieve this aim will prove useful in developing optimal therapies for children with neuroblastoma.


2021 ◽  
Vol 11 (7) ◽  
pp. 3262
Author(s):  
Neill J. Turner

The present Special Issue comprises a collection of articles addressing the many ways in which extracellular matrix (ECM), or its components parts, can be used in regenerative medicine applications. ECM is a dynamic structure, composed of a three-dimensional architecture of fibrous proteins, proteoglycans, and glycosaminoglycans, synthesized by the resident cells. Consequently, ECM can be considered as nature’s ideal biologic scaffold material. The articles in this Special Issue cover a range of topics from the use of ECM components to manufacture scaffold materials, understanding how changes in ECM composition can lead to the development of disease, and how decellularization techniques can be used to develop tissue-derived ECM scaffolds for whole organ regeneration and wound repair. This editorial briefly summarizes the most interesting aspects of these articles.


Sign in / Sign up

Export Citation Format

Share Document